These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Characterization and pharmacokinetic parameters of recombinant soluble interleukin-4 receptor. Jacobs CA; Lynch DH; Roux ER; Miller R; Davis B; Widmer MB; Wignall J; VandenBos T; Park LS; Beckmann MP Blood; 1991 Jun; 77(11):2396-403. PubMed ID: 2039820 [TBL] [Abstract][Full Text] [Related]
49. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125 [TBL] [Abstract][Full Text] [Related]
50. Cure of murine candidiasis by recombinant soluble interleukin-4 receptor. Puccetti P; Mencacci A; Cenci E; Spaccapelo R; Mosci P; Enssle KH; Romani L; Bistoni F J Infect Dis; 1994 Jun; 169(6):1325-31. PubMed ID: 8195611 [TBL] [Abstract][Full Text] [Related]
51. Non-T cell-derived IL-4 plays an important role in IgE production induced by antigen resensitization and is resistant to FK506. Yamashita M; Yamaoka M; Seki N; Fujii T J Immunol; 1996 Jul; 157(2):714-9. PubMed ID: 8752921 [TBL] [Abstract][Full Text] [Related]
52. Cloning, expression, and purification of soluble human interleukin-4 receptor in Streptomyces. Zhang Y; Wang WC; Li Y Protein Expr Purif; 2004 Jul; 36(1):139-45. PubMed ID: 15177295 [TBL] [Abstract][Full Text] [Related]
53. Interleukin-16 inhibits immunoglobulin e production by B lymphocytes. Trudelle A; El Bassam S; Pinsonneault S; Mazer B; Laberge S Int Arch Allergy Immunol; 2007; 143(2):109-18. PubMed ID: 17228167 [TBL] [Abstract][Full Text] [Related]
54. Roles of IL-4 and other factors in the trichosanthin-induced ovalbumin-specific IgE response. Xu WF; Ji YY; Wu YD; Lin GM; Ye M; Sun B Acta Pharmacol Sin; 2001 Aug; 22(8):736-40. PubMed ID: 11749848 [TBL] [Abstract][Full Text] [Related]
56. Prevention of the development of immediate hypersensitivity and airway hyperresponsiveness following in vivo treatment with soluble IL-4 receptor. Renz H; Bradley K; Enssle K; Loader JE; Larsen GL; Gelfand EW Int Arch Allergy Immunol; 1996 Feb; 109(2):167-76. PubMed ID: 8563492 [TBL] [Abstract][Full Text] [Related]
57. Detection of and discrimination between total and free human interleukin-4 and free soluble interleukin-4 receptor by ELISA. Jung T; Bews JP; Enssle KH; Wagner K; Neumann C; Heusser CH J Immunol Methods; 1998 Aug; 217(1-2):41-50. PubMed ID: 9776573 [TBL] [Abstract][Full Text] [Related]
58. Enhancement of human IL-4 activity by soluble IL-4 receptors in vitro. Jung T; Wagner K; Neumann C; Heusser CH Eur J Immunol; 1999 Mar; 29(3):864-71. PubMed ID: 10092089 [TBL] [Abstract][Full Text] [Related]
59. Soluble human interleukin-4 receptor is produced by activated T cells under the control of metalloproteinases. Jung T; Schrader N; Hellwig M; Enssle KH; Neumann C Int Arch Allergy Immunol; 1999 May; 119(1):23-30. PubMed ID: 10341317 [TBL] [Abstract][Full Text] [Related]
60. Recombinant soluble interleukin-4 (IL-4) receptor acts as an antagonist of IL-4 in murine cutaneous Leishmaniasis. Gessner A; Schröppel K; Will A; Enssle KH; Lauffer L; Röllinghoff M Infect Immun; 1994 Oct; 62(10):4112-7. PubMed ID: 7927664 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]